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Glaucoma still represents the most frequent cause of irre-
versible blindness worldwide. The technological advances
lead to innovative surgeries, which are rapidly introduced in
clinical practice. New devices to lower intraocular pressure
without opening the eye wall, bypassing the trabecular mesh-
work, or shunting the aqueous humor to the suprachoroidal
space have been approved undergoing clinical assessment
within clinical trials. Currently, other devices under evalua-
tion are showing promising results. Although these methods
will increase the options available for glaucoma surgeons, it is
unclear if they could replace the present standard surgeries,
such as trabeculectomy, deep sclerectomy, and glaucoma
drainage devices. Moreover, the standard procedures are
continuously modified in different ways to become safer and
more effective.
In this issue L. Choritz et al. investigate whether increased
concentrations of endothelin-1 in the aqueous humor samples
of glaucoma patients influenced wound healing and bleb
fibrosis after standard trabeculectomy with mitomycin C.
Endothelin-1 is a potent vasoconstrictor produced in the eye
by the ciliary epithelium and to be released into the aqueous
humor. It has been implicated in the pathophysiology of
glaucoma. Endothelin-1 is believed to be involved in the
regulation of intraocular pressure (IOP) via effects on the
contractility of ciliary muscle and trabecular meshwork.
W. Niu et al. evaluated the efficacy and safety of three
different biodegradable terpolymers after trabeculectomy
in rabbit eyes compared with Ologen!. The use of these
implants aims to reduce the use of mitomycin C as an anti-
scarring agent.The first implant used was a porous collagen-
glycosaminoglycan matrix, which prevents the adhesion of
the conjunctiva and sclera and the collapse of the sub-
conjunctival space after trabeculectomy, leading to colla-
gen deposition and microcyst formation after penetrating
antiglaucomatous surgery.
Despite the increasing use of antifibrotic agents to mod-
ulate the wound healing response, bleb failure remains a
common complication of glaucoma filtration surgery. In the
paper byW. Liu et al. the needle revision and subconjunctival
mitomycin C injection were compared with needling and
subconjunctival 5-Fluorouracil injection for early dysfunc-
tional filtration blebs after trabeculectomies.
Neovascular glaucoma is one of the most recalcitrant
glaucoma types to treatment and has one of the worst
outcomes compared to other types of glaucoma. Neovascular
glaucoma often needs surgical treatment because medical
treatment fails to adequately control intraocular pressure. In a
retrospective study,H. Yan investigated the long term surgical
outcomes, treating neovascular glaucoma complicated by
vitreous haemorrhage with 23-gauge vitrectomy combined
with phacoemulsification, panretinal laser photocoagulation,
and trabeculectomy without using anti-VEGF agents.
C. Cagini et al. explored the role of canaloplasty in the
surgical management of glaucoma with an extensive review.
Canaloplasty is a nonpenetrating blebless surgical technique
for open-angle glaucoma, similar to viscocanalostomy, in
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which a flexible microcatheter is inserted within Schlemm’s
canal for the entire 360 degrees. The results of this ab
externo technique are really encouraging. S. A. Gandolfi et al.
compared canaloplasty with an ab internominimally invasive
glaucoma surgery, the Hydrus! implant. Both techniques are
innovative and aim to restore the natural pathway, dilating a
large size of Schlemm’s canal.The results of this retrospective,
comparative case series were collected after 2-year follow-up.
A. F. Resende et al. presented a review on the iStent.
This trabecular bypass stent is another minimally invasive
glaucoma surgery device that has quickly gained popularity
in the last years. Randomized controlled trials are still needed
to assess the role of these devices in glaucoma surgery.
Finally, S. Jacob et al. presented a new surgical technique,
the stab incision glaucoma surgery. Even though it looks
similar to standard trabeculectomy the main advantages are
the sliding of the superior conjunctiva without dissecting, the
creation of a superficial corneoscleral tunnel in a single step,
the punch of the internal lip of the tunnel, and finally the
suture of the conjunctival incision alone.
In summary, this issue includes different approaches
presented by diverse authors covering several topics related
to improving of standard filtering surgery and wound healing
and to new surgical techniques. This publication will pro-
vide valuable information that should be helpful in clinical
practice for the whole ophthalmology community, mainly for
glaucoma surgeons.
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